These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11266718)

  • 21. CTLA4Ig inhibits airway eosinophilia and hyperresponsiveness by regulating the development of Th1/Th2 subsets in a murine model of asthma.
    Padrid PA; Mathur M; Li X; Herrmann K; Qin Y; Cattamanchi A; Weinstock J; Elliott D; Sperling AI; Bluestone JA
    Am J Respir Cell Mol Biol; 1998 Apr; 18(4):453-62. PubMed ID: 9533932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of alloantigen-specific T cell tolerance through the treatment of human T lymphocytes with wortmannin.
    Taub DD; Murphy WJ; Asai O; Fenton RG; Peltz G; Key ML; Turcovski-Corrales S; Longo DL
    J Immunol; 1997 Mar; 158(6):2745-55. PubMed ID: 9058809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blockade of CD28-B7, but not CD40-CD154, prevents costimulation of allogeneic porcine and xenogeneic human anti-porcine T cell responses.
    Lee RS; Yamada K; Womer KL; Pillsbury EP; Allison KS; Marolewski AE; Geng D; Thall AD; Arn JS; Sachs DH; Sayegh MH; Madsen JC
    J Immunol; 2000 Mar; 164(6):3434-44. PubMed ID: 10706740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CTLA4Ig Inhibits humoral and cellular immune responses to concordant xenografts.
    Ibrahim S; Xu R; Burdick JF; Baldwin W; Sanfilippo F; Kittur DS
    Transplant Proc; 1996 Apr; 28(2):715-6. PubMed ID: 8623361
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunosuppression of direct T-cell-mediated xenorecognition in vitro.
    Rogers NJ; Mirenda V; Jackson I; Dorling A; Lechler RI
    Transplant Proc; 2001; 33(1-2):697-8. PubMed ID: 11267024
    [No Abstract]   [Full Text] [Related]  

  • 26. CD28-B7 T-cell co-stimulatory blockade potentiates the effects of intrathymic immunomodulation in sensitized graft recipients.
    Stadlbauer TH; Schaub M; Korom S; Onodera K; Sayegh MH; Kupiec-Weglinski JW
    Transplantation; 1997 Dec; 64(12):1816-22. PubMed ID: 9422425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Finally, CTLA4Ig graduates to the clinic.
    Sayegh MH
    J Clin Invest; 1999 May; 103(9):1223-5. PubMed ID: 10225963
    [No Abstract]   [Full Text] [Related]  

  • 28. Preventing allograft rejection with CTLA4IG: effect of donor-specific transfusion route or timing.
    Bolling SF; Lin H; Wei RQ; Turka LA
    J Heart Lung Transplant; 1996 Sep; 15(9):928-35. PubMed ID: 8889989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ICOS costimulation requires IL-2 and can be prevented by CTLA-4 engagement.
    Riley JL; Blair PJ; Musser JT; Abe R; Tezuka K; Tsuji T; June CH
    J Immunol; 2001 Apr; 166(8):4943-8. PubMed ID: 11290772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential inhibition of autoreactive memory- and alloreactive naive T cell responses by soluble cytotoxic T lymphocyte antigen 4 (sCTLA4), CTLA4Ig and LEA29Y.
    Huurman VA; Unger WW; Koeleman BP; Oaks MK; Chandraker AK; Terpstra OT; Roep BO
    Clin Exp Immunol; 2007 Dec; 150(3):487-93. PubMed ID: 17924973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CTLA4Ig inhibits alloantibody responses to repeated blood transfusions.
    Ibrahim S; Jakobs F; Kittur D; Hess A; Linsley PS; Sanfilippo F; Baldwin WM
    Blood; 1996 Dec; 88(12):4594-600. PubMed ID: 8977251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of a novel specificity (CTLA-4) in ATG/TMG globulins and sera from ATG-treated leukemic patients.
    Pistillo MP; Tazzari PL; Bonifazi F; Bandini G; Kato T; Matsui T; Nishioka K; Conte R; Ferrara GB
    Transplantation; 2002 Apr; 73(8):1295-302. PubMed ID: 11981425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of FK506, leflunomide, anti-CD4, and CTLA4IG treatments in rat to mouse pancreas xenograft transplantation.
    Yin DP; Sankary HN; Shen J; Ma LL; Blinder L; Foster P; Williams JW; Chong A
    Transplant Proc; 2000 Aug; 32(5):1003-4. PubMed ID: 10936320
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunosuppressive effects of human CTLA4Ig in a non-human primate model of allogeneic pancreatic islet transplantation.
    Levisetti MG; Padrid PA; Szot GL; Mittal N; Meehan SM; Wardrip CL; Gray GS; Bruce DS; Thistlethwaite JR; Bluestone JA
    J Immunol; 1997 Dec; 159(11):5187-91. PubMed ID: 9548454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blocking T-cell costimulation to prevent transplant rejection.
    Zheng XG; Turka LA
    Transplant Proc; 1998 Aug; 30(5):2146-9. PubMed ID: 9723421
    [No Abstract]   [Full Text] [Related]  

  • 36. CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression.
    Carreno BM; Bennett F; Chau TA; Ling V; Luxenberg D; Jussif J; Baroja ML; Madrenas J
    J Immunol; 2000 Aug; 165(3):1352-6. PubMed ID: 10903737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CTLA4Ig prolongs allograft survival while suppressing cell-mediated immunity.
    Baliga P; Chavin KD; Qin L; Woodward J; Lin J; Linsley PS; Bromberg JS
    Transplantation; 1994 Nov; 58(10):1082-90. PubMed ID: 7526493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease.
    Kouki T; Sawai Y; Gardine CA; Fisfalen ME; Alegre ML; DeGroot LJ
    J Immunol; 2000 Dec; 165(11):6606-11. PubMed ID: 11086105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CTLA-4 is a second receptor for the B cell activation antigen B7.
    Linsley PS; Brady W; Urnes M; Grosmaire LS; Damle NK; Ledbetter JA
    J Exp Med; 1991 Sep; 174(3):561-9. PubMed ID: 1714933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice.
    Freeman GJ; Borriello F; Hodes RJ; Reiser H; Hathcock KS; Laszlo G; McKnight AJ; Kim J; Du L; Lombard DB
    Science; 1993 Nov; 262(5135):907-9. PubMed ID: 7694362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.